TreeWAS – Variant ID: rs12191629

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	0.000	0.002	0.998
K90.0 Coeliac disease	0.000	0.004	0.996
K90 Intestinal malabsorption	0.000	0.733	0.267
K90.8 Other intestinal malabsorption	0.000	0.803	0.197
K90.3 Pancreatic steatorrhoea	0.000	0.808	0.192
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.808	0.192
K90.1 Tropical sprue	0.000	0.808	0.192
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.827	0.173
K90.9 Intestinal malabsorption, unspecified	0.000	0.869	0.131
E83 Disorders of mineral metabolism	0.000	0.877	0.123
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.912	0.088
E83.8 Other disorders of mineral metabolism	0.000	0.912	0.088
E83.2 Disorders of zinc metabolism	0.000	0.912	0.088
E83.0 Disorders of copper metabolism	0.000	0.912	0.088
I46.0 Cardiac arrest with successful resuscitation	0.073	0.927	0.000
E83.5 Disorders of calcium metabolism	0.000	0.929	0.071
E83.4 Disorders of magnesium metabolism	0.000	0.932	0.068
E83.3 Disorders of phosphorus metabolism	0.000	0.956	0.043
I46 Cardiac arrest	0.029	0.971	0.000
I46.1 Sudden cardiac death, so described	0.021	0.979	0.000
I46.9 Cardiac arrest, unspecified	0.020	0.980	0.000
K90-K93 Other diseases of the digestive system	0.000	0.982	0.018
K93 Disorders of other digestive organs in diseases classified elsewhere	0.000	0.986	0.013
E66.9 Obesity, unspecified	0.000	0.989	0.011
E10.9 Without complications	0.000	0.990	0.010
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.000	0.990	0.010
K93.1 Megacolon in Chagas' disease	0.000	0.990	0.010
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.000	0.990	0.010
E10 Insulin-dependent diabetes mellitus	0.000	0.990	0.010
E66 Obesity	0.000	0.991	0.009
E10.2 With renal complications	0.000	0.991	0.009
E10.5 With peripheral circulatory complications	0.000	0.991	0.009
E10.8 With unspecified complications	0.000	0.992	0.008
E10.4 With neurological complications	0.000	0.992	0.008
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.008	0.992	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.000	0.993	0.007
E10.0 With coma	0.000	0.993	0.007
E10.7 With multiple complications	0.000	0.993	0.007
E10.6 With other specified complications	0.000	0.993	0.007
E66.0 Obesity due to excess calories	0.000	0.993	0.007
E66.1 Drug-induced obesity	0.000	0.993	0.007
D12.2 Ascending colon	0.007	0.993	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.994	0.006
E70-E90 Metabolic disorders	0.000	0.994	0.006
E65-E68 Obesity and other hyperalimentation	0.000	0.994	0.006
E66.8 Other obesity	0.000	0.994	0.006
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.994	0.006
Z83.3 Family history of diabetes mellitus	0.006	0.994	0.000
E10.1 With ketoacidosis	0.000	0.994	0.006
E80 Disorders of porphyrin and bilirubin metabolism	0.000	0.994	0.006
K02.9 Dental caries, unspecified	0.000	0.994	0.006
E80.4 Gilbert's syndrome	0.000	0.995	0.005
E10.3 With ophthalmic complications	0.000	0.995	0.005
T50.9 Other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
E65 Localised adiposity	0.000	0.995	0.005
E85 Amyloidosis	0.000	0.995	0.005
E73 Lactose intolerance	0.000	0.995	0.005
E10-E14 Diabetes mellitus	0.000	0.995	0.005
E67 Other hyperalimentation	0.000	0.995	0.005
E68 Sequelae of hyperalimentation	0.000	0.995	0.005
E77 Disorders of glycoprotein metabolism	0.000	0.995	0.005
E76 Disorders of glycosaminoglycan metabolism	0.000	0.995	0.005
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.995	0.005
E72 Other disorders of amino-acid metabolism	0.000	0.995	0.005
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.995	0.005
E70 Disorders of aromatic amino-acid metabolism	0.000	0.995	0.005
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.995	0.005
E13.9 Without complications	0.000	0.995	0.005
E13 Other specified diabetes mellitus	0.000	0.995	0.005
E74 Other disorders of carbohydrate metabolism	0.000	0.995	0.004
E84 Cystic fibrosis	0.000	0.995	0.004
E79 Disorders of purine and pyrimidine metabolism	0.000	0.996	0.004
E80.7 Disorder of bilirubin metabolism, unspecified	0.000	0.996	0.004
E80.6 Other disorders of bilirubin metabolism	0.000	0.996	0.004
E80.5 Crigler-Najjar syndrome	0.000	0.996	0.004
E80.3 Defects of catalase and peroxydase	0.000	0.996	0.004
E80.2 Other porphyria	0.000	0.996	0.004
E80.1 Porphyria cutanea tarda	0.000	0.996	0.004
E80.0 Hereditary erythropoietic porphyria	0.000	0.996	0.004
E85.4 Organ-limited amyloidosis	0.000	0.996	0.004
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.996	0.004
E88 Other metabolic disorders	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
E85.8 Other amyloidosis	0.000	0.996	0.004
E85.3 Secondary systemic amyloidosis	0.000	0.996	0.004
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.996	0.004
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.996	0.004
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.996	0.004
E73.9 Lactose intolerance, unspecified	0.000	0.996	0.004
E73.8 Other lactose intolerance	0.000	0.996	0.004
E73.1 Secondary lactase deficiency	0.000	0.996	0.004
E73.0 Congenital lactase deficiency	0.000	0.996	0.004
E12 Malnutrition-related diabetes mellitus	0.000	0.996	0.004
E67.8 Other specified hyperalimentation	0.000	0.996	0.004
E67.3 Hypervitaminosis D	0.000	0.996	0.004
E67.2 Megavitamin-B6 syndrome	0.000	0.996	0.004
E67.1 Hypercarotenaemia	0.000	0.996	0.004
E67.0 Hypervitaminosis A	0.000	0.996	0.004
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.000	0.996	0.004
E70.8 Other disorders of aromatic amino-acid metabolism	0.000	0.996	0.004
E70.3 Albinism	0.000	0.996	0.004
E70.2 Disorders of tyrosine metabolism	0.000	0.996	0.004
E70.1 Other hyperphenylalaninaemias	0.000	0.996	0.004
E70.0 Classical phenylketonuria	0.000	0.996	0.004
E71.3 Disorders of fatty-acid metabolism	0.000	0.996	0.004
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.000	0.996	0.004
E71.1 Other disorders of branched-chain amino-acid metabolism	0.000	0.996	0.004
E71.0 Maple-syrup-urine disease	0.000	0.996	0.004
E72.9 Disorder of amino-acid metabolism, unspecified	0.000	0.996	0.004
E72.8 Other specified disorders of amino-acid metabolism	0.000	0.996	0.004
E72.5 Disorders of glycine metabolism	0.000	0.996	0.004
E72.4 Disorders of ornithine metabolism	0.000	0.996	0.004
E72.3 Disorders of lysine and hydroxylysine metabolism	0.000	0.996	0.004
E72.2 Disorders of urea cycle metabolism	0.000	0.996	0.004
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.000	0.996	0.004
E72.0 Disorders of amino-acid transport	0.000	0.996	0.004
E75.6 Lipid storage disorder, unspecified	0.000	0.996	0.004
E75.5 Other lipid storage disorders	0.000	0.996	0.004
E75.4 Neuronal ceroid lipofuscinosis	0.000	0.996	0.004
E75.3 Sphingolipidosis, unspecified	0.000	0.996	0.004
E75.2 Other sphingolipidosis	0.000	0.996	0.004
E75.1 Other gangliosidosis	0.000	0.996	0.004
E75.0 GM2 gangliosidosis	0.000	0.996	0.004
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.000	0.996	0.004
E76.8 Other disorders of glucosaminoglycan metabolism	0.000	0.996	0.004
E76.3 Mucopolysaccharidosis, unspecified	0.000	0.996	0.004
E76.2 Other mucopolysaccharidoses	0.000	0.996	0.004
E76.1 Mucopolysaccharidosis, type II	0.000	0.996	0.004
E76.0 Mucopolysaccharidosis, type I	0.000	0.996	0.004
E77.9 Disorder of glycoprotein metabolism, unspecified	0.000	0.996	0.004
E77.8 Other disorders of glycoprotein metabolism	0.000	0.996	0.004
E77.1 Defects in glycoprotein degradation	0.000	0.996	0.004
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.000	0.996	0.004
E13.8 With unspecified complications	0.000	0.996	0.003
E13.7 With multiple complications	0.000	0.996	0.003
E13.6 With other specified complications	0.000	0.996	0.003
E13.5 With peripheral circulatory complications	0.000	0.996	0.003
E13.4 With neurological complications	0.000	0.996	0.003
E13.3 With ophthalmic complications	0.000	0.996	0.003
E13.2 With renal complications	0.000	0.996	0.003
E13.1 With ketoacidosis	0.000	0.996	0.003
E13.0 With coma	0.000	0.996	0.003
H92.1 Otorrhoea	0.000	0.996	0.004
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.996	0.004
E74.9 Disorder of carbohydrate metabolism, unspecified	0.000	0.996	0.003
E74.8 Other specified disorders of carbohydrate metabolism	0.000	0.996	0.003
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.000	0.996	0.003
E74.2 Disorders of galactose metabolism	0.000	0.996	0.003
E74.1 Disorders of fructose metabolism	0.000	0.996	0.003
E74.0 Glycogen storage disease	0.000	0.996	0.003
N41.0 Acute prostatitis	0.004	0.996	0.000
J15.1 Pneumonia due to Pseudomonas	0.004	0.996	0.000
E86 Volume depletion	0.000	0.996	0.004
E84.8 Cystic fibrosis with other manifestations	0.000	0.996	0.003
E84.1 Cystic fibrosis with intestinal manifestations	0.000	0.996	0.003
E84.0 Cystic fibrosis with pulmonary manifestations	0.000	0.996	0.003
C50.3 Lower-inner quadrant of breast	0.000	0.997	0.003
E85.9 Amyloidosis, unspecified	0.000	0.997	0.003
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.000	0.997	0.003
E79.8 Other disorders of purine and pyrimidine metabolism	0.000	0.997	0.003
E79.1 Lesch-Nyhan syndrome	0.000	0.997	0.003
D37.1 Stomach	0.003	0.997	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.000	0.997	0.003
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.997	0.003
E89.3 Postprocedural hypopituitarism	0.000	0.997	0.003
K02.8 Other dental caries	0.000	0.997	0.003
K02 Dental caries	0.000	0.997	0.003
C50.2 Upper-inner quadrant of breast	0.000	0.997	0.003
E40-E46 Malnutrition	0.000	0.997	0.003
E84.9 Cystic fibrosis, unspecified	0.000	0.997	0.003
E88.9 Metabolic disorder, unspecified	0.000	0.997	0.003
E88.8 Other specified metabolic disorders	0.000	0.997	0.003
E88.3 Tumour lysis syndrome	0.000	0.997	0.003
E88.1 Lipodystrophy, not elsewhere classified	0.000	0.997	0.003
J15 Bacterial pneumonia, not elsewhere classified	0.003	0.997	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.000	0.997	0.003
J15.4 Pneumonia due to other streptococci	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
E12.9 Without complications	0.000	0.997	0.003
E12.8 With unspecified complications	0.000	0.997	0.003
E12.7 With multiple complications	0.000	0.997	0.003
E12.6 With other specified complications	0.000	0.997	0.003
E12.5 With peripheral circulatory complications	0.000	0.997	0.003
E12.4 With neurological complications	0.000	0.997	0.003
E12.3 With ophthalmic complications	0.000	0.997	0.003
E12.2 With renal complications	0.000	0.997	0.003
E12.1 With ketoacidosis	0.000	0.997	0.003
E12.0 With coma	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
F45.8 Other somatoform disorders	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.997	0.003
D37.5 Rectum	0.003	0.997	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
D37.0 Lip, oral cavity and pharynx	0.003	0.997	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.997	0.003
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.997	0.003
E89.5 Postprocedural testicular hypofunction	0.000	0.997	0.003
E89.1 Postprocedural hypoinsulinaemia	0.000	0.997	0.003
G44.2 Tension-type headache	0.003	0.997	0.000
R00.0 Tachycardia, unspecified	0.000	0.997	0.003
N61 Inflammatory disorders of breast	0.003	0.997	0.000
J15.9 Bacterial pneumonia, unspecified	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
D37.9 Digestive organ, unspecified	0.003	0.997	0.000
F45.9 Somatoform disorder, unspecified	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.997	0.003
E89.2 Postprocedural hypoparathyroidism	0.000	0.997	0.003
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.003	0.997	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.997	0.003
J15.2 Pneumonia due to staphylococcus	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
F45 Somatoform disorders	0.003	0.997	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.997	0.002
T40.4 Other synthetic narcotics	0.003	0.997	0.000
T42.4 Benzodiazepines	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
J14 Pneumonia due to Haemophilus influenzae	0.003	0.997	0.000
K02.5 Caries with pulp exposure	0.000	0.997	0.002
K02.4 Odontoclasia	0.000	0.997	0.002
K02.3 Arrested dental caries	0.000	0.997	0.002
K02.2 Caries of cementum	0.000	0.997	0.002
K02.0 Caries limited to enamel	0.000	0.997	0.002
K91.3 Postoperative intestinal obstruction	0.000	0.997	0.002
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.997	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.997	0.000
K91.5 Postcholecystectomy syndrome	0.000	0.997	0.002
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.997	0.002
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.997	0.002
E45 Retarded development following protein-energy malnutrition	0.000	0.997	0.002
E43 Unspecified severe protein-energy malnutrition	0.000	0.997	0.002
E42 Marasmic kwashiorkor	0.000	0.997	0.002
E41 Nutritional marasmus	0.000	0.997	0.002
E40 Kwashiorkor	0.000	0.997	0.002
E89.4 Postprocedural ovarian failure	0.000	0.997	0.002
J15.8 Other bacterial pneumonia	0.002	0.997	0.000
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.002	0.997	0.000
J15.5 Pneumonia due to Escherichia coli	0.002	0.997	0.000
J15.3 Pneumonia due to streptococcus, group B	0.002	0.997	0.000
T42.1 Iminostilbenes	0.002	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
H40.2 Primary angle-closure glaucoma	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
K91.1 Postgastric surgery syndromes	0.000	0.998	0.002
F45.2 Hypochondriacal disorder	0.002	0.998	0.000
E88.2 Lipomatosis, not elsewhere classified	0.000	0.998	0.002
J03.9 Acute tonsillitis, unspecified	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
D37.7 Other digestive organs	0.002	0.998	0.000
D37.3 Appendix	0.002	0.998	0.000
K22.9 Disease of oesophagus, unspecified	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
Z13.9 Special screening examination, unspecified	0.002	0.998	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.998	0.002
R20.2 Paraesthesia of skin	0.002	0.998	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.002	0.998	0.000
D37.6 Liver, gallbladder and bile ducts	0.002	0.998	0.000
F45.0 Somatisation disorder	0.002	0.998	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.002	0.998	0.000
O16 Unspecified maternal hypertension	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.002	0.998	0.000
Z97.5 Presence of (intra-uterine) contraceptive device	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
J09-J18 Influenza and pneumonia	0.002	0.998	0.000
I45.1 Other and unspecified right bundle-branch block	0.002	0.998	0.000
J10 Influenza due to identified influenza virus	0.002	0.998	0.000
J12.9 Viral pneumonia, unspecified	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
J12 Viral pneumonia, not elsewhere classified	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
E15 Nondiabetic hypoglycaemic coma	0.000	0.998	0.002
C50.0 Nipple and areola	0.000	0.998	0.002
K02.1 Caries of dentin	0.000	0.998	0.002
D37.2 Small intestine	0.002	0.998	0.000
F45.4 Persistent somatoform pain disorder	0.002	0.998	0.000
F45.1 Undifferentiated somatoform disorder	0.002	0.998	0.000
J15.0 Pneumonia due to Klebsiella pneumoniae	0.002	0.998	0.000
F45.3 Somatoform autonomic dysfunction	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.000	0.998	0.002
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
E44.1 Mild protein-energy malnutrition	0.000	0.998	0.002
E44.0 Moderate protein-energy malnutrition	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
E50-E64 Other nutritional deficiencies	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.000	0.998	0.002
C50.8 Overlapping lesion of breast	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
N83.1 Corpus luteum cyst	0.000	0.998	0.002
T36.0 Penicillins	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.002	0.998	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.002	0.998	0.000
T21.0 Burn of unspecified degree of trunk	0.002	0.998	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
J10.0 Influenza with pneumonia, influenza virus identified	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.002	0.998	0.000
J11 Influenza, virus not identified	0.002	0.998	0.000
J09 Influenza due to certain identified influenza virus	0.002	0.998	0.000
J10.8 Influenza with other manifestations, influenza virus identified	0.002	0.998	0.000
O34.1 Maternal care for tumour of corpus uteri	0.000	0.998	0.002
Z74.0 Reduced mobility	0.000	0.998	0.002
Y86 Sequelae of other accidents	0.000	0.998	0.002
N60.0 Solitary cyst of breast	0.002	0.998	0.000
O14.1 Severe preeclampsia	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.002	0.998	0.000
J12.8 Other viral pneumonia	0.002	0.998	0.000
J12.3 Human metapneumovirus pneumonia	0.002	0.998	0.000
J12.2 Parainfluenza virus pneumonia	0.002	0.998	0.000
J12.1 Respiratory syncytial virus pneumonia	0.002	0.998	0.000
J12.0 Adenoviral pneumonia	0.002	0.998	0.000
J13 Pneumonia due to Streptococcus pneumoniae	0.002	0.998	0.000
D22.3 Melanocytic naevi of other and unspecified parts of face	0.000	0.998	0.002
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
C50 Malignant neoplasm of breast	0.000	0.998	0.002
S00.8 Superficial injury of other parts of head	0.002	0.998	0.000
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.002	0.998	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.000	0.998	0.002
O34.6 Maternal care for abnormality of vagina	0.000	0.998	0.002
O34.5 Maternal care for other abnormalities of gravid uterus	0.000	0.998	0.002
O34.3 Maternal care for cervical incompetence	0.000	0.998	0.002
O34.0 Maternal care for congenital malformation of uterus	0.000	0.998	0.002
S50.0 Contusion of elbow	0.002	0.998	0.000
J17 Pneumonia in diseases classified elsewhere	0.002	0.998	0.000
T21 Burn and corrosion of trunk	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
H43.8 Other disorders of vitreous body	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
E61 Deficiency of other nutrient elements	0.000	0.998	0.002
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.998	0.002
E63 Other nutritional deficiencies	0.000	0.998	0.002
E56 Other vitamin deficiencies	0.000	0.998	0.002
E51 Thiamine deficiency	0.000	0.998	0.002
E50 Vitamin A deficiency	0.000	0.998	0.002
E60 Dietary zinc deficiency	0.000	0.998	0.002
E59 Dietary selenium deficiency	0.000	0.998	0.002
E58 Dietary calcium deficiency	0.000	0.998	0.002
E54 Ascorbic acid deficiency	0.000	0.998	0.002
E52 Niacin deficiency [pellagra]	0.000	0.998	0.002
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.000	0.998	0.002
T20-T25 Burns and corrosions of external body surface, specified by site	0.002	0.998	0.000
T20.0 Burn of unspecified degree of head and neck	0.002	0.998	0.000
Z83.5 Family history of eye and ear disorders	0.002	0.998	0.000
E61.1 Iron deficiency	0.000	0.998	0.002
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
K31.7 Polyp of stomach and duodenum	0.002	0.998	0.000
T23.3 Burn of third degree of wrist and hand	0.002	0.998	0.000
T23.1 Burn of first degree of wrist and hand	0.002	0.998	0.000
Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device	0.000	0.998	0.002
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.998	0.002
D37.4 Colon	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
T93.2 Sequelae of other fractures of lower limb	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
T25 Burn and corrosion of ankle and foot	0.002	0.998	0.000
J11.1 Influenza with other respiratory manifestations, virus not identified	0.002	0.998	0.000
K82.8 Other specified diseases of gallbladder	0.002	0.998	0.000
Z97.1 Presence of artificial limb (complete)(partial)	0.002	0.998	0.000
J11.8 Influenza with other manifestations, virus not identified	0.001	0.998	0.000
J16.8 Pneumonia due to other specified infectious organisms	0.001	0.998	0.000
J16.0 Chlamydial pneumonia	0.001	0.998	0.000
Q82.8 Other specified congenital malformations of skin	0.000	0.998	0.002
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.002	0.998	0.000
U89 Agent resistant to other and unspecified antibiotics	0.000	0.998	0.002
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.001	0.998	0.000
T21.3 Burn of third degree of trunk	0.002	0.998	0.000
T23.7 Corrosion of third degree of wrist and hand	0.001	0.998	0.000
T23.6 Corrosion of second degree of wrist and hand	0.001	0.998	0.000
T23.5 Corrosion of first degree of wrist and hand	0.001	0.998	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.001	0.998	0.000
T20 Burn and corrosion of head and neck	0.002	0.998	0.000
Z97 Presence of other devices	0.002	0.998	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
U89.8 Agent resistant to other single specified antibiotic	0.000	0.998	0.002
D17.7 Benign lipomatous neoplasm of other sites	0.002	0.998	0.000
J11.0 Influenza with pneumonia, virus not identified	0.001	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
J17.8 Pneumonia in other diseases classified elsewhere	0.001	0.998	0.000
J17.1 Pneumonia in viral diseases classified elsewhere	0.001	0.998	0.000
T21.7 Corrosion of third degree of trunk	0.001	0.998	0.000
T21.6 Corrosion of second degree of trunk	0.001	0.998	0.000
T21.5 Corrosion of first degree of trunk	0.001	0.998	0.000
T21.4 Corrosion of unspecified degree of trunk	0.001	0.998	0.000
T21.1 Burn of first degree of trunk	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations